NasdaqGM - Delayed Quote USD

Tema Oncology ETF (CANC)

23.80
-0.38
(-1.55%)
At close: May 22 at 4:00:00 PM EDT
23.80
+0.16
+(0.70%)
After hours: May 22 at 4:04:07 PM EDT

Top 10 Holdings (43.73% of Total Assets)

SymbolCompany% Assets
Revolution Medicines, Inc. 5.74%
Eli Lilly and Company 5.37%
Roche Holding AG 4.93%
BridgeBio Pharma, Inc. 4.38%
AstraZeneca PLC 4.16%
Novartis AG 4.13%
Nuvalent, Inc. 3.90%
Exelixis, Inc. 3.83%
Bristol-Myers Squibb Company 3.73%
Summit Therapeutics Inc. 3.56%

Sector Weightings

SectorCANC
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.11%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.23
Price/Sales 0.17
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

ETF Overview

Category Health
Fund Family Tema Global Limited
Net Assets 67.75M
YTD Daily Total Return -0.53%
Yield 2.89%
Legal Type Exchange Traded Fund

Related Tickers